Delivery Order SPE2DB24D1006-SPE2DB25FCERP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $2,321.58 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity: 7 units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $68,576.46 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (seven-count units) under a firm fixed price contract. The contract was competitively awarded with no set-aside designation and includes an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,143.08 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (7-count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,308.10 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Orilissa 150 mg tablets (7-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of July 21, 2025, and performance in Conshohocken, Pennsylvania. Orilissa is an endometriosis treatment medication, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Orilissa 150 mg tablets (7-count packaging) at a ceiling value of $9,477.76. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is June 23, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.91 to AmerisourceBergen Drug Corp for 7 tablets of Orilissa 150 mg on September 8, 2025, with a completion date of September 9, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a procurement of the endometriosis medication Orilissa to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $678 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will deliver 150mg tablets of Orilissa to a facility in Conshohocken, Pennsylvania, with performance spanning July 19-20, 2023. As a major supplier of pharmaceuticals and medical goods, Amerisourcebergen will support the Defense Logistics Agency in providing this medication to DOD personnel and affiliates. No...
- The Defense Logistics Agency Troop Support Medical awarded a $6,810.85 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 7 units of 150 mg Orilissa tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning September 13, 2023 through September 14, 2023. No additional details were provided regarding the original solicitation or whether this award was made against an...
- The Defense Logistics Agency awarded a $2,411.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 14 tablets of Orilissa 200 mg to be delivered from their Conshohocken, Pennsylvania facility by July 24, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract. The Defense Logistics Agency is a combat support agency within the Department of Defense responsible for worldwide logistics support....
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCERPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Orilissa 200 mg tablets in quantities of 14 units, with a ceiling value of $10,900.19. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The contract was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, and has an ultimate completion date of May 21, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular order for Orilissa, a medication used in treating endometriosis, exemplifies AmerisourceBergen's role in providing specialized healthcare commodities through the Defense Logistics Agency's medical supply chain to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 5/20/25 |